Telegram
Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиMinerva Neurosciences Мультипликаторы 2011-2024 | NERV
Мультипликаторы по годам Minerva Neurosciences
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-1.6 | -0.3 | -0.1 | 68.9 | -4.4 | -4.9 | -7.5 | -10.5 | -4.5 | -1.0 | - | - | - |
P/S |
- | - | - | 3.2 | - | - | - | - | - | - | - | - | - |
EPS |
-4.6 | -6.0 | -9.3 | 0.1 | -1.9 | -1.3 | -0.8 | -1.0 | -1.2 | -4.5 | -0.8 | - | - |
EV (Enterprise Value) |
91.7 млн | 49 млн | 12.7 млн | 113 млн | 342 млн | 243 млн | 263 млн | 270 млн | 135 млн | 54.1 млн | 7.18 млн | 190 тыс. | - |
EBITDA per Share |
-3.55 | -4.72 | -8.5 | 0.0483 | -1.94 | -1.33 | -1.08 | -0.957 | -1.11 | -4.31 | - | - | - |
EV/EBITDA |
-0.2 | 55.5 | -3.9 | -3.8 | -5.2 | -8.3 | -4.5 | -0.7 | - | - | - | ||
PEG |
0.0 | 0.0 | 0.0 | 0.67 | 0.1 | 0.09 | -0.47 | -0.72 | -0.06 | 0.0 | - | - | - |
P/B |
-1.7 | -0.5 | 0.5 | 2.5 | 11.3 | 2.7 | 1.8 | 3.1 | 2.2 | 1.1 | - | - | - |
P/CF |
-3.2 | -0.4 | -0.2 | -4.0 | -7.2 | -5.8 | 78.0 | -12.7 | -5.0 | -1.5 | - | - | - |
ROE % |
105.44 | 160.35 | -625.73 | 3.69 | -259.84 | -55.58 | -23.95 | -29.29 | -48.95 | -110.49 | - | - | - |
ROA % |
-52.73 | -58.29 | -64.71 | 3.37 | -93.14 | -36.06 | -17.16 | -23.35 | -32.80 | -83.13 | - | - | - |
ROCE % |
81.24 | 126.00 | -568.80 | 3.39 | -107.05 | -38.17 | -23.28 | -24.49 | -33.80 | -84.49 | - | - | - |
Current Ratio |
0.7 | 0.7 | 1.1 | 8.7 | 7.1 | 24.9 | 18.9 | 8.7 | 6.3 | 5.5 | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Minerva Neurosciences
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-1.03 | -1.12 | -1.31 | - | -1.29 | -1.63 | -1.83 | - | -1.72 | -1.98 | -0.21 | -0.17 | -0.19 | 0.75 | -0.31 | -0.77 | -0.36 | -0.32 | -0.41 | - | -0.31 | -0.32 | -0.32 | - | -0.28 | -0.27 | -0.3 | - | -0.24 | -0.18 | -0.29 | - | -0.24 | -0.27 | -0.31 | - | -1.53 | -2.55 | -0.43 | - | -0.12 | -0.1 | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | -1 | - | -0.98 | -1.3 | -1.5 | - | -1.41 | -1.68 | -0.18 | -0.17 | -0.19 | 0.75 | -0.31 | -0.83 | -0.37 | -0.33 | -0.42 | -0.35 | -0.32 | -0.33 | -0.33 | -0.25 | -0.28 | -0.27 | -0.3 | -0.26 | -0.24 | -0.17 | -0.28 | -0.33 | -0.23 | -0.26 | -0.3 | -0.4 | -1.53 | -2.32 | -0.38 | -0.33 | -0.12 | -0.1 | - | - | - | - | - | - | - | - | - |
ROE % |
163.13 | 172.56 | 227.07 | 1478.90 | 1446.11 | 1364.89 | 1231.61 | -81.47 | -95.37 | -77.99 | 7.36 | 3.69 | -90.10 | -124.96 | -225.94 | -259.84 | -166.77 | -129.83 | -98.80 | -55.58 | -40.83 | -36.07 | -29.62 | -23.95 | -32.95 | -32.34 | -29.83 | -29.29 | -35.67 | -38.46 | -45.49 | -48.95 | -48.15 | -90.14 | -115.80 | -110.49 | -106.58 | -56.27 | -20.53 | -14.82 | -4.28 | -1.86 | - | - | - | - | - | - | - | - | - |
ROA % |
-46.67 | -45.83 | -50.02 | -38.79 | -48.23 | -46.12 | -42.75 | -27.36 | -40.07 | -44.71 | 16.58 | 3.37 | -22.53 | -26.46 | -93.80 | -93.14 | -64.03 | -54.65 | -47.56 | -36.06 | -26.48 | -23.97 | -20.29 | -17.16 | -24.32 | -24.53 | -23.13 | -23.35 | -26.50 | -27.35 | -31.44 | -32.80 | -33.45 | -65.93 | -86.21 | -83.13 | -79.55 | -41.55 | -14.54 | -10.25 | -2.96 | -1.29 | - | - | - | - | - | - | - | - | - |
ROCE % |
123.10 | 129.33 | 176.29 | 1204.95 | 1178.18 | 1114.85 | 1006.98 | -68.10 | -81.96 | -70.55 | 10.26 | 3.51 | -99.15 | -135.20 | -237.68 | -273.10 | -171.68 | -134.03 | -101.91 | -57.31 | -49.46 | -44.36 | -37.44 | -31.28 | -32.76 | -31.86 | -29.14 | -28.49 | -34.58 | -37.13 | -43.89 | -47.20 | -46.84 | -89.25 | -112.08 | -106.54 | -102.21 | -51.88 | -19.48 | -14.39 | -4.27 | -1.88 | - | - | - | - | - | - | - | - | - |
Current Ratio |
0.8 | 0.8 | 0.7 | 0.7 | 0.8 | 0.9 | 1.0 | 1.1 | 1.4 | 1.5 | 1.7 | 11.6 | 11.6 | 11.6 | 11.6 | 1.6 | 1.6 | 1.6 | 1.6 | 2.9 | 2.9 | 2.9 | 2.9 | 3.5 | 3.5 | 3.5 | 3.5 | 4.9 | 4.9 | 4.9 | 4.9 | 3.0 | 3.0 | 3.0 | 3.0 | 4.0 | 4.0 | 4.0 | 4.0 | 3.2 | 3.2 | 3.2 | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD